← All stocks

Quince Therapeutics, Inc.

QNCX Net selling
CIK 0001662774 #4870 in the set updated 18 Sep 2026
Bought (120 mo)
$11.88M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$29.23M
$0.00 on a plan · $9.71M straight out of an exercise
Sold at will
$19.52M
32 of 63 sales
Net
−$17.34M
−$7.63M against sales at will

By person

21 insiders · 141 transactions
6.2×

Dirk Thye holds 6.2 times base salary in stock. $3.45M of shares against $550.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dirk Thye last reported holding, valued at $3.47, the price Common Stock was last bought or sold at on the open market here, on 26 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
PFIZER INC entity
10% owner
$850.00K (1)
$14.87M (1)
−$14.02M
2,879,973
$9.99M
Lamond David
Director
$8.65M (32)
+$8.65M
8,031,665
$27.87M
+120.2%
Lynch Casey
Chief Executive Officer
$4.41M (25)
−$4.41M
1,180,580
$4.10M
−4.8%
Detke Michael J.
Chief Medical Officer
$4.15M (9) scheduled
−$4.15M
140,000
$485.80K
LOWE CHRISTOPHER P.
Interim CEO, COO & CFO
$3.67M (10) scheduled
−$3.67M
265,000
$919.55K
EPIQ Capital Group, LLC entity
IA/Managing Member of 10% Owne
$1.33M (15)
+$1.33M
19,880,610
$68.99M
+0.1%
Holsinger Leslie
EVP, Preclinical Development
$1.23M (6) scheduled
−$1.23M
148,080
$513.84K
McLoughlin Margaret
Director
$19.19K (2)
$691.91K (9) scheduled
−$672.72K
8,000
$27.76K
YOUNG KEVIN
Director
$510.00K (1)
+$510.00K
30,000
$104.10K
Thye Dirk
CEO and CMO
$317.46K (4)
+$317.46K
994,885
$3.45M
+359.9%
Benatti Luca
Director
$173.50K (1)
−$173.50K
39,179
$135.95K
−51.2%
Hannah Brendan
CBO, COO & CCO
$111.72K (7)
+$111.72K
361,827
$1.26M
+218.6%
RYAN UNA S
Director
$48.88K (1)
+$48.88K
2,875
$9.98K
Ryan Charles S.
President
$31.45K (1)
+$31.45K
130,009
$451.13K
+75.5%
McDowell Caryn Gordon
Chief Legal & Adm. Officer
$30.92K (1)
−$30.92K
122,500
$425.08K
Dominy Stephen S.
Chief Scientific Officer
$10.99K (1)
+$10.99K
1,217,086
$4.22M
+0.1%
Monohon Ted
Chief Accounting Officer & VP
$1.83K (1)
−$1.83K
27,440
$95.22K
LAMOND PIERRE
10% owner
2,886,530
$10.02M
Takeda Ventures, Inc. entity
10% owner
2,679,802
$9.30M
Low Philip S
Director
519,283
$1.80M
Smith Karen L.
Chief Medical Officer
24,336
$84.45K

No percentages here. This company's share count has moved by a factor of 160.3 over the window, from 1,017,063 to 163,007,943 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
McLoughlin Margaret
8 Oct 2021
Director
Sold after exercise
1,000
$88.93
$88.93K
LOWE CHRISTOPHER P.
5 Oct 2021
COO & Chief Financial Officer
Sold after exercise
4,963
$98.50
$488.86K
LOWE CHRISTOPHER P.
16 Aug 2021
COO & Chief Financial Officer
Sold after exercise
2,077
$98.90
$205.42K
LOWE CHRISTOPHER P.
16 Aug 2021
COO & Chief Financial Officer
Sold after exercise
1,100
$97.28
$107.01K
LOWE CHRISTOPHER P.
16 Aug 2021
COO & Chief Financial Officer
Sold after exercise
2,330
$96.32
$224.43K
LOWE CHRISTOPHER P.
16 Aug 2021
COO & Chief Financial Officer
Sold after exercise
7,335
$95.02
$696.97K
LOWE CHRISTOPHER P.
16 Aug 2021
COO & Chief Financial Officer
Sold after exercise
9,158
$94.23
$862.96K
McLoughlin Margaret
16 Aug 2021
Director
Sold after exercise
48
$98.90
$4.75K
McLoughlin Margaret
16 Aug 2021
Director
Sold after exercise
423
$97.55
$41.26K
McLoughlin Margaret
16 Aug 2021
Director
Sold after exercise
1,429
$96.51
$137.91K
McLoughlin Margaret
16 Aug 2021
Director
Sold after exercise
1,044
$95.57
$99.78K
McLoughlin Margaret
16 Aug 2021
Director
Sold after exercise
3,056
$94.55
$288.94K
Detke Michael J.
10 Aug 2021
Chief Medical Officer
Sold after exercise
10,000
$100.00
$1.00M
Detke Michael J.
7 Jul 2021
Chief Medical Officer
Sold after exercise
523
$56.99
$29.81K
Detke Michael J.
7 Jul 2021
Chief Medical Officer
Sold after exercise
6,942
$56.27
$390.63K
Detke Michael J.
7 Jul 2021
Chief Medical Officer
Sold after exercise
4,353
$55.38
$241.07K
Detke Michael J.
7 Jul 2021
Chief Medical Officer
Sold after exercise
1,648
$54.37
$89.60K
Detke Michael J.
7 Jul 2021
Chief Medical Officer
Sold after exercise
3,934
$53.24
$209.45K
Detke Michael J.
6 Jul 2021
Chief Medical Officer
Sold after exercise
288
$55.01
$15.84K
Detke Michael J.
6 Jul 2021
Chief Medical Officer
Sold after exercise
8,260
$53.91
$445.30K
Detke Michael J.
6 Jul 2021
Chief Medical Officer
Sold after exercise
32,313
$53.43
$1.73M
LOWE CHRISTOPHER P.
28 Jun 2021
COO & Chief Financial Officer
Sold after exercise
1,044
$56.16
$58.63K
LOWE CHRISTOPHER P.
28 Jun 2021
COO & Chief Financial Officer
Sold after exercise
4,153
$55.11
$228.87K
LOWE CHRISTOPHER P.
28 Jun 2021
COO & Chief Financial Officer
Sold after exercise
7,079
$54.13
$383.19K
LOWE CHRISTOPHER P.
28 Jun 2021
COO & Chief Financial Officer
Sold after exercise
7,724
$53.39
$412.38K
Holsinger Leslie
14 Dec 2020
Executive Vice President
Sold after exercise
900
$32.59
$29.33K
Holsinger Leslie
14 Dec 2020
Executive Vice President
Sold after exercise
400
$32.59
$13.03K
Holsinger Leslie
14 Dec 2020
Executive Vice President
Sold after exercise
9,525
$31.79
$302.80K
Holsinger Leslie
14 Dec 2020
Executive Vice President
Sold after exercise
13,200
$30.91
$408.01K
Holsinger Leslie
14 Dec 2020
Executive Vice President
Sold after exercise
14,275
$30.15
$430.39K
Holsinger Leslie
14 Dec 2020
Executive Vice President
Sold after exercise
1,700
$28.80
$48.96K

What was left out

Form 4 filings counted 164
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 10
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 31
Sales at will 32
Transactions with no price 0
Shares from compensation/vesting 16,076,553
Sales filed before the plan box existed 31
History held since 9 May 2019